share_log

HC Wainwright & Co. Initiates Coverage On Finch Therapeutics Group with Buy Rating, Announces Price Target of $17

HC Wainwright & Co. Initiates Coverage On Finch Therapeutics Group with Buy Rating, Announces Price Target of $17

HC Wainwright & Co.以买入评级启动对Finch Therapeutics集团的报道,宣布目标股价为17美元
Benzinga Real-time News ·  2022/08/09 06:26

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Finch Therapeutics Group (NASDAQ:FNCH) with a Buy rating and announces Price Target of $17.

HC Wainwright & Co. 分析师弗农·贝纳迪诺以买入评级开始报道芬奇治疗集团(纳斯达克股票代码:FNCH),并宣布目标股价为17美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发